Emflaza Interactions
There are 539 drugs known to interact with Emflaza (deflazacort), along with 18 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 144 are major, 387 are moderate, and 8 are minor.
- View all 539 medications that may interact with Emflaza
- View Emflaza alcohol/food interactions (2)
- View Emflaza disease interactions (18)
Most frequently checked interactions
View interaction reports for Emflaza (deflazacort) and the medicines listed below.
- acetaminophen
- Blincyto (blinatumomab)
- calcium carbonate
- cefazolin
- cholecalciferol
- CoQ10 (ubiquinone)
- Cytoxan (cyclophosphamide)
- diphenhydramine
- Emla (lidocaine / prilocaine topical)
- Entresto (sacubitril / valsartan)
- eplerenone
- Exondys 51 (eteplirsen)
- fluoxetine
- ibuprofen
- Imbruvica (ibrutinib)
- Imfinzi (durvalumab)
- Jardiance (empagliflozin)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- lansoprazole
- lisinopril
- multivitamin
- Nutropin AQ (somatropin)
- Ofev (nintedanib)
- Pomalyst (pomalidomide)
- prednisone
- spironolactone
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- testosterone
- Vitamin D3 (cholecalciferol)
Emflaza alcohol/food interactions
There are 2 alcohol/food interactions with Emflaza (deflazacort).
Emflaza disease interactions
There are 18 disease interactions with Emflaza (deflazacort) which include:
- (+) tuberculin test
- depression/psychoses
- diabetes
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticalism
- hypothyroidism
- MI
- myopathy
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- PUD
- strongyloidiasis
- thromboembolism
- hepatic impairment
- infections
More about Emflaza (deflazacort)
- Emflaza consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.